REPORTS

Let’s Pullulate and Expand Your Business

Equine Pharmaceuticals and Supplements Market - Global Professional Analysis and Forecast to 2026

Mar 23, 2020  |  182 PAGES  |  REPORT CODE: CMM273341
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Equine Pharmaceuticals and Supplements market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.

This report presents the market size and development trends by detailing the Equine Pharmaceuticals and Supplements market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Equine Pharmaceuticals and Supplements market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Equine Pharmaceuticals and Supplements industry and will help you to build a panoramic view of the industrial development.

Equine Pharmaceuticals and Supplements Market, By Type:

  • Pharmaceuticals

  • Supplements

Equine Pharmaceuticals and Supplements Market, By Application:

  • Thoroughbred Horse

  • Other Types of Horses

Some of the leading players are as follows:

  • Merck Animal Health

  • Bayer Animal Health

  • Boehringer Ingelheim

  • Dechra Veterinary Products

  • Virbac

  • Kyoritsu Seiyaku

  • Audevard

  • Elanco Animal Health

  • Protexin Healthcare

  • CEVA

  • Vetoquinol

  • Zoetis

  • Ouro Fino Saude

  • Norbrook Equine

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Equine Pharmaceuticals and Supplements Market: Technology Type Analysis

  • 4.1 Equine Pharmaceuticals and Supplements Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Equine Pharmaceuticals and Supplements Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Pharmaceuticals

    • 4.3.2 Supplements

5 Equine Pharmaceuticals and Supplements Market: Product Analysis

  • 5.1 Equine Pharmaceuticals and Supplements Product Market Share Analysis, 2018 & 2026

  • 5.2 Equine Pharmaceuticals and Supplements Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Equine Pharmaceuticals and Supplements Market: Application Analysis

  • 6.1 Equine Pharmaceuticals and Supplements Application Market Share Analysis, 2018 & 2026

  • 6.2 Equine Pharmaceuticals and Supplements Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Thoroughbred Horse

    • 6.3.2 Other Types of Horses

7 Equine Pharmaceuticals and Supplements Market: Regional Analysis

  • 7.1 Equine Pharmaceuticals and Supplements Regional Market Share Analysis, 2018 & 2026

  • 7.2 Equine Pharmaceuticals and Supplements Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Merck Animal Health

    • 9.1.1 Merck Animal Health Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Bayer Animal Health

    • 9.2.1 Bayer Animal Health Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Boehringer Ingelheim

    • 9.3.1 Boehringer Ingelheim Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Dechra Veterinary Products

    • 9.4.1 Dechra Veterinary Products Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Virbac

    • 9.5.1 Virbac Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Kyoritsu Seiyaku

    • 9.6.1 Kyoritsu Seiyaku Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Audevard

    • 9.7.1 Audevard Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Elanco Animal Health

    • 9.8.1 Elanco Animal Health Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Protexin Healthcare

    • 9.9.1 Protexin Healthcare Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 CEVA

    • 9.10.1 CEVA Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Vetoquinol

    • 9.11.1 Vetoquinol Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Zoetis

    • 9.12.1 Zoetis Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Ouro Fino Saude

    • 9.13.1 Ouro Fino Saude Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Norbrook Equine

    • 9.14.1 Norbrook Equine Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

 

The List of Tables and Figures (Totals 77 Figures and 146 Tables)

  • Figure Pharmaceuticals Equine Pharmaceuticals and Supplements market, 2015 - 2026 (USD Million)

  • Figure Supplements Equine Pharmaceuticals and Supplements market, 2015 - 2026 (USD Million)

  • Figure Thoroughbred Horse market, 2015 - 2026 (USD Million)

  • Figure Other Types of Horses market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)

  • Table North America Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table North America Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table North America Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Canada Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Canada Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Europe Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)

  • Table Europe Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Europe Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Europe Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Germany Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Germany Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table France Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table France Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Italy Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Italy Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Spain Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Spain Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table China Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table China Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Japan Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Japan Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table India Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table India Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table MEA Equine Pharmaceuticals and Supplements market, by country, 2015 - 2026 (USD Million)

  • Table MEA Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table MEA Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table MEA Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Equine Pharmaceuticals and Supplements market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Equine Pharmaceuticals and Supplements market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Equine Pharmaceuticals and Supplements market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Merck Animal Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Animal Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dechra Veterinary Products Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Virbac Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Kyoritsu Seiyaku Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Audevard Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Elanco Animal Health Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Protexin Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CEVA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vetoquinol Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Zoetis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ouro Fino Saude Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Norbrook Equine Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top